Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AROMASCAN PLC U.S. SUBSIDIARY BEGINNING OPERATIONS IN SEPTEMBER

This article was originally published in The Rose Sheet

Executive Summary

AROMASCAN PLC U.S. SUBSIDIARY BEGINNING OPERATIONS IN SEPTEMBER will offer U.S. companies aroma-analysis instruments that are said to emulate the human nose. The company noted that its aroma-analysis technology "has substantial commercial potential as it offers significant advantages over existing methods of aroma analysis" such as human sensory panels and "expensive" chemical component analysis, both of which are used extensively for quality control and product development in the toiletries, perfume, food and beverage industries. The parent firm is a start-up company based in Crewe, England. It went public June 17.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS000766

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel